Delivery Order SPE2DB22D3010-SPE2DB24FP2LJ
Award Date
5/21/24
Potential Completion Date
5/22/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,463.52 firm-fixed price Delivery Order is for the supply of the prescription medication Qsymia 7.5 mg-46 mg capsules, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,590.29, is for the delivery of the prescription medication Qsymia in 3.75 mg-23 mg capsule form. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.40, is for the delivery of the prescription medication Qsymia 3.75 mg-23 mg capsules. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, including 7.5 mg-46 mg Qsymia capsules. The firm-fixed-price contract has a ceiling value of $1,362.66 and an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products, including specialty medications, generic...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,607.18 firm fixed-price contract is for the delivery of the prescription medication Qsymia 7.5 mg-46 mg capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $4,097.22 to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is for the pharmaceutical product Qsymia 7.5 mg-46 mg capsules, and has a completion date of May 7, 2024. Amerisourcebergen, as a major supplier of pharmaceuticals and medical supplies to federal agencies, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Qsymia 15mg-92mg in 30-count packages. The contract, valued at $2,990.04, is a delivery order with a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,767.32, is for the supply of Qsymia 15 mg-92 mg capsules. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of the prescription drug QSYMIA 7.5MG-46MG 30S. The contract, which is a firm fixed price type, has a ceiling value of $1,507.20 and runs through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) for the pharmaceutical drug Qsymia in the amount of $2,011.00. The delivery order has a firm fixed price and an ultimate completion date of March 26, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to the Department of Defense through multiple...